Article Text

Download PDFPDF

MDSCs enhance tumor cell proliferation in a caspase-1 related inflammasome cytokines dependent way
  1. Qi Zeng1,
  2. Jesse Qualliotine2,
  3. Richard Blosser2,
  4. Drew Pardoll2 and
  5. Young Kim1
  1. Aff1 grid.21107.350000000121719311Johns Hopkins University Baltimore MD USA
  2. Aff2 grid.21107.350000000121719311Johns Hopkins University School of Medicine Baltimore MD USA

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Meeting abstracts

Myeloid-derived-suppression cells (MDSCs) are believed to be an important immune evasion mechanism by suppressing T cells. We investigated whether MDSCs have direct T cell independent pro-carcinogenic effect on tumor cells. We sorted the monocytic CD14+/CD11b+/HLA-DRlow MDSCs from head and neck squamous cell carcinoma (HNSCC) patients and found that MDSCs increased the proliferation index of HNSCC cells. Similar results were seen from co-culturing murine MDSCs and CT26 and B16 cells. Supernatant from the MDSCs were found to secrete inflammasome cytokines IL-1b and IL-18. MDSC's enhancement of proliferative index of the tumor was found to be caspase-1 dependent using FLICA. To test this in vivo, T cell depleted caspase-1 null mice showed significant decrease in tumor growth rate. To confirm the importance of myeloid inflammasome signaling in carcinogenesis, we suppressed MyD88 gene in tumor cell line Cal27 and found that the ability of MDSCs to promoting tumor proliferation is diminished. Taken together, our findings demonstrate that MDSCs can promote tumor cells proliferation on a inflammasome cytokines dependent manner.